Acta Med. 2018, 61: 150-152

https://doi.org/10.14712/18059694.2018.134

Anaplastic Carcinoma Thyroid in a Young Child – an Extremely Rare Occurrence

Suresh Chandra Sharmaa, Pirabu Sakthivela, Sarath Raveendrana, Chirom Amit Singha, Tripti Nakrab, Shipra Agarwalb

aDepartment of Otorhinolaryngology & Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India
bDepartment of Pathology, All India Institute of Medical Sciences, New Delhi, India

Received August 26, 2018
Accepted November 12, 2018

References

1. Dermody S, Walls A, Harley EH Jr. Pediatric thyroid cancer: An update from the SEER database 2007–2012. Int J Pediatr Otorhinolaryngol 2016; 89: 121–6. <https://doi.org/10.1016/j.ijporl.2016.08.005>
2. Hogan AR, Zhuge Y, Perez EA, Koniaris LG, Lew JI, Sola JE. Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res 2009; 156: 167–72. <https://doi.org/10.1016/j.jss.2009.03.098>
3. Meier JD, Grimmer JF. Evaluation and management of neck masses in children. Am Fam Physician 2014; 89: 353–8.
4. Chiacchio S, Lorenzoni A, Boni G, Rubello D, Elisei R, Mariani G. Anaplastic thyroid cancer: prevalence, diagnosis and treatment. Minerva Endocrinol 2008; 33: 341–57.
5. Mon R, Newlon J. Anaplastic carcinoma of the thyroid in a 12-year old girl. J Ped Surg Case Reports 2015; 3: 404–6. <https://doi.org/10.1016/j.epsc.2015.08.004>
6. Keutgen XM, Sadowski SM, Kebebew E. Management of anaplastic thyroid cancer. Gland Surg 2015; 4: 44–51.
7. Moore JH Jr, Bacharach B, Choi HY. Anaplastic transformation of metastatic follicular carcinoma of the thyroid. J Surg Oncol 1985; 29: 216–21. <https://doi.org/10.1002/jso.2930290403>
8. Herle AJ, Uller RP. Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas. J Clin Invest 1975; 56: 272–7. <https://doi.org/10.1172/JCI108090> <PubMed>
9. Lee JW, Yoon DY, Choi CS, Chang SK, Yun EJ, Seo YL, Rho YS, Cho SJ, Kim KH. Anaplastic thyroid carcinoma: computed tomographic differentiation from other thyroid masses. Acta Radiol 2008; 49: 321–7. <https://doi.org/10.1080/02841850701813120>
10. Hoang JK, Branstetter BF 4th, Gafton AR, Lee WK, Glastonbury CM. Imaging of thyroid carcinoma with CT and MRI: approaches to common scenarios. Cancer Imaging 2013; 13: 128–39. <https://doi.org/10.1102/1470-7330.2013.0013> <PubMed>
11. Marcus C, Whitworth PW, Surasi DS, Pai SI, Subramaniam RM. PET/CT in the management of thyroid cancers. AJR Am J Roentgenol 2014; 202: 1316–29. <https://doi.org/10.2214/AJR.13.11673>
12. Perri F, Lorenzo GD, Scarpati GD, Buonerba C. Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options. World J Clin Oncol 2011; 2: 150–7. <https://doi.org/10.5306/wjco.v2.i3.150> <PubMed>
13. Käsmann L, Bolm L, Janssen S, Rades D. Prognostic Factors for Survival in Patients Treated with Multimodal Therapy for Anaplastic Thyroid Cancer. Anticancer Res 2016; 36: 4697–700. <https://doi.org/10.21873/anticanres.11023>
14. Pudney D, Lau H, Ruether JD, Falck V. Clinical experience of the multimodality management of anaplastic thyroid cancer and literature review. Thyroid 2007; 17: 1243–50. <https://doi.org/10.1089/thy.2007.0026>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive